Survival Outcomes for Right- Versus Left-Sided Colon Cancer and Rectal Cancer in Patients Receiving Regorafenib And/or Trifluridine/tipiracil for Refractory Metastatic Colorectal Cancer: Findings from the Multicenter Retrospective ReTrITa Study.Carlo Signorelli,Maria Alessandra Calegari,Alessandro Passardi,Jessica Lucchetti,Ina Valeria Zurlo,Cristina Morelli,Emanuela Dell'Aquila,Donatello Gemma,Alessandra Emiliani,Giulia Arrivi,Federica Zoratto,Mario Giovanni Chilelli,Maria Grazia Morandi,Fiorenza Santamaria, Manuela Dettori,Antonella Cosimati,Rosa Saltarelli,Alessandro Minelli, Emanuela Lucci-Cordisco, Michele BassoJournal of Clinical Oncology(2025)引用 0|浏览3AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要